```json
[
  {
    "disorder": "Delirium",
    "criteria": "A. A disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift atten-tion) and awareness (reduced orientation to the environment).\nB. The disturbance develops over a short period of time (usually hours to a few days), rep-resents a change from baseline attention and awareness, and tends to fluctuate in se-verity during the course of a day.\nC. An additional disturbance in cognition (e.g., memory deficit, disorientation, language,visuospatial ability, or perception).\nD. The disturbances in Criteria A and C are not better explained by another preexisting,established, or evolving neurocognitive disorder and do not occur in the context of asevere ly reduced level of arousal, such as coma.\nE. There is evidence from the history, physical examination, or laboratory findings that thedisturbance is a direct physiological consequence of another medical condition, sub-stance intoxication or withdrawal (i.e., due to a drug of abuse or to a medication), orexposure to a toxin, or is due to multiple etiologies.\nSpecify whether:\nSubstance intoxication delirium: This diagnosis should be made instead of sub-stance intoxication when the symptoms in Criteria A and C predominate in the clinicalpicture and when they are sufficiently severe to warrant clinical attention.\nSubstance withdrawal delirium: This diagnosis should be made instead of sub-stance withdrawal when the symptoms in Criteria A and C predominate in the clinicalpicture and when they are sufficiently severe to warrant clinical attention.\nMedication-induced delirium: This diagnosis applies when the symptoms in CriteriaA and C arise as a side effect of a medication taken as prescribed.\n293.0 (F05) Delirium due to another medical condition: There is evidence from thehistory, physical examination, or laboratory findings that the disturbance is attributableto the physiological consequences of another medical condition.\n293.0 (F05) Delirium due to multiple etiologies: There is evidence from the history,physical examination, or laboratory findings that the delirium has more than one etiol-ogy (e.g., more than one etiological medical condition; another medical condition plussubstance intoxication or medication side effect).\nSpecify if:\nAcute: Lasting a few hours or days.\nPersistent: Lasting weeks or months.\nSpecify if:\nHyperactive: The individual has a hyperactive level of psychomotor activity that may beaccompanied by mood lability, agitation, and/or refusal to cooperate with medical care.\nHypoactive: The individual has a hypoactive level of psychomotor activity that may beaccompanied by sluggishness and lethargy that approaches stupor.\nMixed level of activity: The individual has a normal level of psychomotor activity eventhough attention and awareness are disturbed. Also includes individuals whose activitylevel rapidly fluctuates."
  },
  {
    "disorder": "Major Neurocognitive Disorder",
    "criteria": "A. Evidence of significant cognitive decline from a previous level of performance in oneor more cognitive domains (complex attent ion, executive function, learning and mem-ory, language, perceptual-motor, or social cognition) based on:\n1. Concern of the individual, a knowledgeable informant, or the clinician that there hasbeen a significant decline in cognitive function; and\n2. A substantial impairment in cognitive performance, preferably documented by stan-dardized neuropsychological testing or, in its absence, another quantified clinicalassessment.\nB. The cognitive deficits interfere with independence in everyday activities (i.e., at a min-imum, requiring assistance with complex instrumental activities of daily living such aspaying bills or managing medications).\nC. The cognitive deficits do not occur e xclusively in the context of a delirium.\nD. The cognitive deficits are not better explai ned by another mental disorder (e.g., majordepressive disorder, schizophrenia).\nSpecify whether due to:\nAlzheimer’s disease (pp. 611–614)\nFrontotemporal lobar degeneration (pp. 614–618)\nLewy body disease (pp. 618–621)\nVascular disease (pp. 621–624)\nTraumatic brain injury (pp. 624–627)\nSubstance/medication use (pp. 627–632)\nHIV infection (pp. 632–634)\nPrion disease (pp. 634–636)\nParkinson’s disease (pp. 636–638)\nHuntington’s disease (pp. 638–641)\nAnother medical condition (pp. 641–642)\nMultiple etiologies (pp. 642–643)\nUnspecified (p. 643)\nSpecify:\nWithout behavioral disturbance: If the cognitive disturbance is not accompanied byany clinically significant behavioral disturbance.\nWith behavioral disturbance (specify disturbance): If the cognitive disturbance is ac-companied by a clinically significant behavioral disturbance (e.g., psychotic symptoms,mood disturbance, agitation, apathy, or other behavioral symptoms).\nSpecify current severity:\nMild: Difficulties with instrumental activities of daily living (e.g., housework, managingmoney).\nModerate: Difficulties with basic activities of daily living (e.g., feeding, dressing).\nSevere: Fully dependent."
  },
  {
    "disorder": "Mild Neurocognitive Disorder",
    "criteria": "A. Evidence of modest cognitive decline from a previous level of performance in one ormore cognitive domains (complex attention, executive function, learning and memory,language, perceptual-motor, or social cognition) based on:\n1. Concern of the individual, a knowledgeable informant, or the clinician that there hasbeen a mild decline in cognitive function; and\n2. A modest impairment in cognitive per formance, preferably documented by stan-dardized neuropsychological testing or, in its absence, another quantified clinicalassessment.\nB. The cognitive deficits do not interfere with capacity for independence in everydayactivities (i.e., complex instrumental activities of daily living such as paying bills ormanaging medications are preserved, but gr eater effort, compensatory strategies, oraccommodation may be required).\nC. The cognitive deficits do not occur e xclusively in the context of a delirium.\nD. The cognitive deficits are not better explai ned by another mental disorder (e.g., majordepressive disorder, schizophrenia).\nSpecify whether due to:\nAlzheimer’s disease (pp. 611–614)\nFrontotemporal lobar degeneration (pp. 614–618)\nLewy body disease (pp. 618–621)\nVascular disease (pp. 621–624)\nTraumatic brain injury (pp. 624–627)\nSubstance/medication use (pp. 627–632)\nHIV infection (pp. 632–634)\nPrion disease (pp. 634–636)\nParkinson’s disease (pp. 636–638)\nHuntington’s disease (pp. 638–641)\nAnother medical condition (pp. 641–642)\nMultiple etiologies (pp. 642–643)\nUnspecified (p. 643)\nSpecify:\nWithout behavioral disturbance: If the cognitive disturbance is not accompanied byany clinically significant behavioral disturbance.\nWith behavioral disturbance (specify disturbance): If the cognitive disturbance is ac-companied by a clinically significant behavioral disturbance (e.g., psychotic symptoms,mood disturbance, agitation, apathy, or other behavioral symptoms)."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Alzheimer’s Disease",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is insidious onset and gradual progression of impairment in one or more cognitivedomains (for major neurocognitive disorder, at least two domains must be impaired).\nC. Criteria are met for either probable or possible Alzheimer’s disease as follows:\nFor major neurocognitive disorder:\nProbable Alzheimer’s disease is diagnosed if either of the following is present; oth-erwise, possible Alzheimer’s disease should be diagnosed.\n1. Evidence of a causative Alzheimer’s disease genetic mutation from family historyor genetic testing.\n2. All three of the following are present:\na. Clear evidence of decline in memory and learning and at least one other cogni-tive domain (based on detailed history or serial neuropsychological testing).\nb. Steadily progressive, gradual decline in cognition, without extended plateaus.\nc. No evidence of mixed etiology (i.e., absence of other neurodegenerative orcerebrovascular disease, or another neurological, mental, or systemic diseaseor condition likely contributing to cognitive decline).\nFor mild neurocognitive disorder:\nProbable Alzheimer’s disease is diagnosed if there is evidence of a causative Alz-heimer’s disease genetic mutation from either genetic testing or family history.\nPossible Alzheimer’s disease is diagnosed if there is no evidence of a causative Alz-heimer’s disease genetic mutation from either genetic testing or family history, and allthree of the following are present:\n1. Clear evidence of decline in memory and learning.\n2. Steadily progressive, gradual decline in cognition, without extended plateaus.\n3. No evidence of mixed etiology (i.e., absence of other neurodegenerative or cere-brovascular disease, or another neurologica l or systemic disease or condition likelycontributing to cognitive decline).\nD. The disturbance is not better explained by cerebrovascular disease, another neurode-generative disease, the effects of a substance, or another mental, neurological, or sys-temic disorder."
  },
  {
    "disorder": "Major or Mild Frontotemporal Neurocognitive Disorder",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. The disturbance has insidious onset and gradual progression.\nC. Either (1) or (2):\n1. Behavioral variant:\na. Three or more of the following behavioral symptoms:\ni. Behavioral disinhibition.\nii. Apathy or inertia.\niii. Loss of sympathy or empathy.\niv. Perseverative, stereotyped or compulsive/ritualistic behavior.\nv. Hyperorality and dietary changes.\nb. Prominent decline in social cognition and/or executive abilities.\n2. Language variant:\na. Prominent decline in language ability, in the form of speech production, wordfinding, object naming, grammar, or word comprehension.\nD. Relative sparing of learning and memory and perceptual-motor function.\nE. The disturbance is not better explained by cerebrovascular disease, another neurode-generative disease, the effects of a substance, or another mental, neurological, or sys-temic disorder.\nProbable frontotemporal neurocognitive disorder is diagnosed if either of the followingis present; otherwise, possible frontotemporal neurocognitive disorder should be di-agnosed:\n1. Evidence of a causative frontotemporal neur ocognitive disorder genetic mutation, fromeither family history or genetic testing.\n2. Evidence of disproportionate frontal and/or temporal lobe involvement from neuroim-aging.\nPossible frontotemporal neurocognitive disorder is diagnosed if there is no evidenceof a genetic mutation, and neuroimaging has not been performed."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder With Lewy Bodies",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. The disorder has an insidious onset and gradual progression.\nC. The disorder meets a combination of core diagnostic features and suggestive diagnos-tic features for either probable or possibl e neurocognitive disorder with Lewy bodies.\nFor probable major or mild neurocognitive disorder with Lewy bodies, the indi-vidual has two core features, or one suggestive feature with one or more core features.\nFor possible major or mild neurocognitive disorder with Lewy bodies, the individ-ual has only one core feature, or one or more suggestive features.\n1. Core diagnostic features:\na. Fluctuating cognition with pronounced variations in attention and alertness.\nb. Recurrent visual hallucinations that are well formed and detailed.\nc. Spontaneous features of parkinsonism, with onset subsequent to the develop-ment of cognitive decline.\n2. Suggestive diagnostic features:\na. Meets criteria for rapid eye movement sleep behavior disorder.\nb. Severe neuroleptic sensitivity.\nD. The disturbance is not better explained by cerebrovascular disease, another neurode-generative disease, the effects of a substance, or another mental, neurological, or sys-temic disorder."
  },
  {
    "disorder": "Major or Mild Vascular Neurocognitive Disorder",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. The clinical features are consistent with a vascular etiology, as suggested by either of\nthe following:\n1. Onset of the cognitive deficits is temporally related to one or more cerebrovascular\nevents.\n2. Evidence for decline is prominent in complex attention (including processing\nspeed) and frontal-executive function.\nC. There is evidence of the presence of cere brovascular disease from history, physical\nexamination, and/or neuroimaging consider ed sufficient to account for the neurocog-\nnitive deficits.\nD. The symptoms are not better explained by another brain disease or systemic disorder.\nProbable vascular neurocognitive disorder is diagnosed if one of the following is pres-ent; otherwise possible vascular neurocognitive disorder should be diagnosed:\n1. Clinical criteria are supported by neuroimaging evidence of significant parenchymal in-jury attributed to cerebrovascula r disease (neuroimaging-supported).\n2. The neurocognitive syndrome is temporally related to one or more documented cere-brovascular events.\n3. Both clinical and genetic (e.g., cerebral aut osomal dominant arteriopathy with subcorticalinfarcts and leukoencephalopathy) evidence of cerebrovascular disease is present.\nPossible vascular neuroc ognitive disorder is diagnosed if the clinical criteria are metbut neuroimaging is not available and the tem poral relationship of the neurocognitive syn-drome with one or more cerebrovascular events is not established."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Traumatic Brain Injury",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is evidence of a traumatic brain injury—that is, an impact to the head or othermechanisms of rapid movement or displacement of the brain within the skull, with oneor more of the following:\n1. Loss of consciousness.\n2. Posttraumatic amnesia.\n3. Disorientation and confusion.\n4. Neurological signs (e.g., neuroimaging demonstrating injury; a new onset of sei-zures; a marked worsening of a preexisting seizure disorder; visual field cuts; an-osmia; hemiparesis).\nC. The neurocognitive disorder presents imm ediately after the occurrence of the trau-matic brain injury or immediately after recovery of consciousness and persists past theacute post-injury period."
  },
  {
    "disorder": "Substance/Medication-Induced Major or Mild Neurocognitive Disorder",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. The neurocognitive impairments do not occur exclusively during the course of a delir-ium and persist beyond the usual duration of intoxication and acute withdrawal.\nC. The involved substance or medication and duration and extent of use are capable ofproducing the neurocognitive impairment.\nD. The temporal course of the neurocognitive deficits is consistent with the timing of sub-stance or medication use and abstinence (e.g., the deficits remain stable or improveafter a period of abstinence).\nE. The neurocognitive disorder is not attributable to another medical condition or is notbetter explained by another mental disorder.\nSpecify if:\nPersistent: Neurocognitive impairment continues to be significant after an extendedperiod of abstinence."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to HIV Infection",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is documented infection with human immunodeficiency virus (HIV).\nC. The neurocognitive disorder is not bette r explained by non-HIV conditions, includingsecondary brain diseases such as progre ssive multifocal leukoencephalopathy orcryptococcal meningitis.\nD. The neurocognitive disorder is not attribut able to another medical condition and is notbetter explained by a mental disorder."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Prion Disease",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is insidious onset, and rapid progression of impairment is common.\nC. There are motor features of prion disease, such as myoclonus or ataxia, or biomarkerevidence.\nD. The neurocognitive disorder is not attribut able to another medical condition and is notbetter explained by another mental disorder."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Parkinson’s Disease",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. The disturbance occurs in the setting of established Parkinson’s disease.\nC. There is insidious onset and gradual progression of impairment.\nD. The neurocognitive disorder is not attribut able to another medical condition and is notbetter explained by another mental disorder.\nMajor or mild neurocognitive disorder probably due to Parkinson’s disease shouldbe diagnosed if 1 and 2 are both met. Major or mild neurocognitive disorder possiblydue to Parkinson’s disease should be diagnosed if 1 or 2 is met:\n1. There is no evidence of mixed etiology (i.e., absence of other neurodegenerative orcerebrovascular disease or another neurological, mental, or systemic disease or con-dition likely contributing to cognitive decline).\n2. The Parkinson’s disease clearly precedes the onset of the neurocognitive disorder."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Huntington’s Disease",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is insidious onset and gradual progression.\nC. There is clinically established Huntington’ s disease, or risk for Huntington’s diseasebased on family history or genetic testing.\nD. The neurocognitive disorder is not attribut able to another medical condition and is notbetter explained by another mental disorder."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Another Medical Condition",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is evidence from the history, physical examination, or laboratory findings that theneurocognitive disorder is the pathophysi ological consequence of another medicalcondition.\nC. The cognitive deficits are not better explained by another mental disorder or anotherspecific neurocognitive disorder (e.g., Alzheimer’s disease, HIV infection)."
  },
  {
    "disorder": "Major or Mild Neurocognitive Disorder Due to Multiple Etiologies",
    "criteria": "A. The criteria are met for major or mild neurocognitive disorder.\nB. There is evidence from the history, physical examination, or laboratory findings that theneurocognitive disorder is the pathophysiological consequence of more than one etio-logical process, excluding substances (e.g., neurocognitive disorder due to Alzhei-mer’s disease with subsequent development of vascular neurocognitive disorder).\nNote: Please refer to the diagnostic criteria for the various neurocognitive disorders dueto specific medical conditions for guidance on establishing the pa rticular etiologies.\nC. The cognitive deficits are not better ex plained by another mental disorder and do notoccur exclusively during the course of a delirium."
  }
]
```